The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(9-((2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-tetrahydrofuran-2-yl)-9H-purin-6-yl)-3-(4-propoxyphenyl)urea ID: ALA206807
PubChem CID: 10648594
Max Phase: Preclinical
Molecular Formula: C22H27N7O6
Molecular Weight: 485.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCOc1ccc(NC(=O)Nc2ncnc3c2ncn3[C@@H]2O[C@H](C(=O)NCC)[C@@H](O)[C@H]2O)cc1
Standard InChI: InChI=1S/C22H27N7O6/c1-3-9-34-13-7-5-12(6-8-13)27-22(33)28-18-14-19(25-10-24-18)29(11-26-14)21-16(31)15(30)17(35-21)20(32)23-4-2/h5-8,10-11,15-17,21,30-31H,3-4,9H2,1-2H3,(H,23,32)(H2,24,25,27,28,33)/t15-,16+,17-,21+/m0/s1
Standard InChI Key: ALQXBWHXWIDDKS-GRXQJBFDSA-N
Molfile:
RDKit 2D
35 38 0 0 1 0 0 0 0 0999 V2000
0.5787 -20.5989 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1977 -20.8816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2454 -21.0838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8403 -19.8090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4621 -21.6660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8600 -20.3928 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9104 -20.6035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3297 -21.9052 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6527 -19.8131 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2815 -21.6618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0201 -22.3425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5318 -20.8761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6630 -20.9415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0859 -22.2447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7749 -22.3300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3198 -20.6226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7502 -21.7591 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3357 -20.4516 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4940 -19.8200 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.9330 -21.1773 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.7132 -20.9215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3221 -21.4762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0897 -20.7863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7566 -20.3006 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1769 -21.6066 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9310 -21.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0133 -22.7595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7665 -23.0942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4344 -22.6083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3441 -21.7840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5907 -21.4530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1889 -22.9420 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8551 -22.4554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6096 -22.7891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6979 -23.6094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13 17 1 0
13 18 1 0
16 19 2 0
7 9 1 0
10 12 1 0
14 17 2 0
16 20 1 0
2 1 1 1
20 21 1 0
1 3 1 0
21 22 1 0
1 4 1 0
18 23 1 0
5 2 1 0
23 24 2 0
2 6 1 0
23 25 1 0
3 7 1 0
25 26 1 0
3 8 2 0
26 27 2 0
4 9 2 0
27 28 1 0
5 10 1 0
28 29 2 0
5 11 1 6
29 30 1 0
6 12 1 0
30 31 2 0
31 26 1 0
7 13 2 0
29 32 1 0
8 14 1 0
32 33 1 0
10 15 1 6
33 34 1 0
12 16 1 1
34 35 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 485.50Molecular Weight (Monoisotopic): 485.2023AlogP: 1.01#Rotatable Bonds: 8Polar Surface Area: 172.75Molecular Species: NEUTRALHBA: 10HBD: 5#RO5 Violations: ┄HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.48CX Basic pKa: 2.15CX LogP: 0.70CX LogD: 0.70Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.31Np Likeness Score: -0.46
References 1. González MP, Terán C, Teijeira M.. (2006) A topological function based on spectral moments for predicting affinity toward A3 adenosine receptors., 16 (5): [PMID:16356715 ] [10.1016/j.bmcl.2005.11.063 ]